|
Gerald Raymond is a Pediatric Neurologist and research scientist at Kennedy Krieger Institute. Dr. Raymond is also an Associate Professor of Neurology at Johns Hopkins University and on the medical staff in the Department of Pediatrics and Neurology at Johns Hopkins Hospital.
Biographical Sketch:
Dr. Raymond graduated in 1980 from Fairfield University with a BS in Biology and went on to graduate from University of Connecticut in 1984. Upon graduation, he was a resident in Pediatrics at Johns Hopkins University and Neurology at Massachusetts General Hospital. He completed training in Clinical Genetics at Harvard in 1990.
For the past 10 years, Dr. Raymond has been a Pediatric Neurologist at Kennedy Krieger Institute. He joined Johns Hopkins School of Medicine in 1993 and is presently an Associate Professor in Neurology. He serves on the Medical Staff in the Department of Pediatrics and Neurology at Johns Hopkins Hospital.
Research Summary:
Dr. Raymond is a pediatrician, a geneticist, and a neurologist with a special interest in developmental and neurogenetic disorders affecting children and adults.
Dr. Raymond’s work combines careful clinical analysis with technological advances in neuroimaging, genetics, and neuroscience to permit delineation and characterization of neurogenetic disorders. His activities are at the interface between clinical neurology and basic sciences which provide a unique opportunity to understand the developing brain, the biological basis of disease and to develop new strategies for prevention and therapy. He has completed an FDA-funded study of the treatment of peroxisome assembly disorders using the compound docosahexaenoic acid with arachidonic acid and is presently principal investigator of a study examining adrenomyeloneuropathy, the adult form of the condition adrenoleukodystrophy.
RESEARCH PARTICIPANTS NEEDED:Adrenomyeloneuropathy (AMN) Research Study
Recent Publications/Presentations:
Hoover-Fong JE, Gerhaghty MT, Raymond GV, Thomas GH. Gabapentin interference with urine histidine as measured by the Beckman amino acid analyser. J Inherit Metab Dis. 2001 June; 24(3):415-416.
Beaty TH, Wang H, Hetmanski JB, Fan YT, Zeiger JS, Liang KY, Chiu YF, Vanderkolk C, Seifert KC, Wulfsberg EA, Raymond G, Panny SR, McIntosh I. A case-control study of nonsyndromic oral clefts in Maryland. Ann Epidemiol 2001; 11:432-442.
Bezman L, Moser AB, Raymond GV, Rinaldo P, Watkins PA, Smith KD, Kass NE, Moser HW. Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening. Ann Neurol 2001 49:512-517.
Williard DE, Nwankwo JO, Kaduce TL, Harmon SD, Irons M, Moser HW, Raymond GV, Spector AA. Indentification of a fatty acid Delta(6)-desaturase deficiency in human skin fibroblasts. J Lipid Res. 2001 42(4):501-508.
Van Geel BM, Bezman L, Loes D, Moser HW, Raymond GV. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol. 2001 Feb; 49(2):186-194.
Ito R, Melhem ER, Mori S, Eichler FS, Raymond GV, Moser HW. Diffusion tensor brain MR imaging in X-linked cerebral adrenoleukodystrophy. Neurology. 2001 Feb; 56(4): 544-547. | 